Company page

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. (CGTX) is a publicly traded company in the American market, with a market capitalization of approximately $82.3 million. The company focuses on developing therapies for neurodegenerative diseases. Its innovative approach aims to address unmet medical needs in this critical area of healthcare.